Royal Osteoporosis Society appoints Tracey Bleakley as Chief Executive

The Royal Osteoporosis Society (ROS) has appointed Tracey Bleakley as its new Chief Executive.

She will take up the role on 30 November 2026, leading the UK’s only national charity dedicated to improving bone health and ending the pain and disability caused by osteoporosis.

Tracey brings extensive senior leadership experience across the NHS and the charity sector. She has held senior NHS roles including Chief Executive of NHS Norfolk and Waveney Integrated Care Board and has led national charities including Hospice UK and Dying Matters. Most recently, she served as Interim Chief Executive of SafeLives.

She joins ROS at a pivotal time for bone health. Osteoporosis affects millions of people across the UK, yet too many people remain undiagnosed and untreated until they experience painful, life-changing fractures. ROS is working to transform diagnosis, treatment and support, including by securing the effective rollout of Fracture Liaison Services across England.

Tracey Bleakley said:

“I am delighted to be joining the Royal Osteoporosis Society. For forty years, ROS has worked with people affected by osteoporosis, healthcare professionals, supporters and decision-makers to improve bone health across the UK.

“This is a vital moment for the cause. We know that earlier diagnosis, effective treatment and better access to specialist services can prevent fractures and protect people’s independence. I look forward to working with colleagues, volunteers, members, supporters and partners to build on the Society’s achievements and create a future with no more broken bones and no more broken lives.”

Professor Neil Gittoes, Chair of the Royal Osteoporosis Society, said:

“We are delighted to welcome Tracey as our new Chief Executive. She brings a breadth of experience from health and the charity sector, and a track record of delivering better outcomes for people and communities.

All of us on the Board of Trustees look forward to working with her to increase the visibility of osteoporosis, provide information and support to those affected and accelerate the changes in policy and practice needed to prevent avoidable fractures.”

Tracey succeeds Craig Jones, who stepped down in July 2026 after six years as Chief Executive. Thom Harvey has led the charity as Interim Chief Executive during the transition.